Drugs with this side effect
- 17-hydroxyprogesterone: postmarketing
- 18F-flutemetamol
- 4-AP
- 5-ASA: very rare, postmarketing
- 5-FU: 1%
- 5-aza-2'-deoxycytidine: 29.3%
- 5-azacytidine: very common, 1.96% - 29.1%
- 5-fluorocytosine
- 68Ga
- AMD3100
- Anidulafungin: 3.2% - 11.5%
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Azarga
- BCNU: 3.33%
- BPTI
- Bivalirudin: postmarketing
- Buscopan
- CAS 76095-16-4: 1.3%
- CAS 76420-72-9
- CGP 19835A: common, very common, 21%
- Cancidas: 0% - 10%
- Carfilzomib: 0.19% - 34.6%
- Colimycin M: 10% - 16.6%
- EACA
- Eptifibatide: 0.192%
- FAMP: 9% - 22%
- FK463
- FTY720: common, 8%
- Fe(III: postmarketing, 1.3% - 11%
- Forteo: 3.6%
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132: 16% - 21%
- Glat copolymer
- Goserelin: 0% - 3.82%
- Humalog
- ICI 182,780: 4.43% - 14.9%
- Insulin: uncommon, 1.4% - 4.4%
- K779: 1% - 34%
- Kaluril
- L-Dmp: infrequent
- LMWH: 3.3%
- LY146032: postmarketing, 1.6% - 5.2%
- Leuprorelin: postmarketing, 2% - 8%
- Lisinopril: 0.4% - 7.4%
- Lovaza
- Lutalyse
- MK-462
- Madopar
- Meropenem anhydrous
- Mersyndol
- Metrodin
- N-acetylcysteine
- Nafarelin
- Octreotide: common, 0-2%
- Optison: postmarketing, uncommon
- Org 37462: very rare
- PCI-32765
- PGE2
- Photofrin: 4.04% - 30.2%
- Photofrin II: common
- Refludan
- Revasc
- Romidepsin: 2.29% - 21.3%
- S-benzoylmercaptoacetyltriglycine
- SU5416
- Stalevo 50
- Supremon
- TMC435: 11.8%
- Terlipressin: postmarketing
- TlCl
- Triptorelin: 1.1%
- UDCA
- VACV: postmarketing, rare, uncommon, 7% - 38%
- Vancocine: postmarketing
- abacavir
- abacavir-lamivudine
- abiraterone: 0.9% - 2.4%
- acamprosate: frequent
- acebutolol: 2% - 6%
- acetaminophen
- acetylcholine
- acyclovir: postmarketing, rare
- adenosine: 12% - 28%
- afatinib
- almotriptan: infrequent
- alprazolam: 1.5%
- amantadine: rare
- ambrisentan: postmarketing, 4.21% - 5.38%
- amifostine
- amiloride
- amiodarone: postmarketing
- amlodipine
- amlodipine besylate
- amphetamine
- amphotericin B: 2.47% - 29.1%
- amsacrine
- anagrelide: 11% - 11.9%
- anastrozole: 7.57% - 21%
- anthracycline: 3% - 23%
- apomorphine
- apraclonidine: postmarketing
- aprepitant
- argatroban: 8.1% - 8.8%
- aripiprazole
- arsenic
- arsenic trioxide: common
- asenapine
- aspirin
- atazanavir: uncommon
- atenolol: 0.6% - 6%
- atorvastatin
- atosiban
- atovaquone: 15% - 21%
- atracurium
- axitinib: 3% - 15%
- azelastine: postmarketing
- azithromycin
- aztreonam
- baclofen: rare, common, 0% - 2%
- balsalazide
- belinostat: 6% - 22%
- benazepril
- benazeprilat
- bendamustine
- benzathine penicillin
- benzocaine
- benzylpenicilloyl
- bepridil: 0% - 8.7%
- betahistine: very rare
- betaxolol: postmarketing, 1.3% - 2.7%
- bexarotene: 10%
- bicalutamide: 7%
- bicarbonate
- bimatoprost
- bisoprolol: 1.1% - 1.5%
- bleomycin hydrochloride
- boceprevir: very common, 16%
- bortezomib: 0.302% - 22.6%
- bosentan: 4%
- bosutinib
- bretylium
- brimonidine: rare
- brinzolamide: postmarketing, 0.2% - 2%
- bromocriptine: postmarketing, rare
- budesonide
- bupivacaine
- buprenorphine: 3%
- bupropion: rare, infrequent, 0% - 2%
- buspirone: infrequent
- busulfan: 25%
- butorphanol: infrequent
- cabazitaxel: 1%
- cabergoline: postmarketing, 3.3%
- caffeine: 2.17%
- candesartan
- candesartan cilexetil
- capecitabine: 1% - 16%
- captopril
- carbamazepine: very rare
- carbidopa: 0.4% - 1.6%
- carboplatin
- carboprost
- carnitine: 3% - 11%
- carteolol
- carvedilol: 0.5% - 21.3%
- cefaclor
- cefepime
- cefoxitin
- cefpodoxime
- ceftobiprole
- cefuroxime
- cefuroxime axetil
- celecoxib: 2.8%
- celiprolol
- cephem
- cerivastatin
- cetirizine: postmarketing
- cevimeline
- chlorpromazine
- ciclesonide
- cidofovir: postmarketing, common, 8.15% - 22.6%
- cilazapril
- cilostazol
- cinacalcet: 9%
- ciprofloxacin: postmarketing
- cisatracurium
- cisplatin
- citalopram: postmarketing, infrequent, uncommon
- cladribine: common, 5% - 7%
- clarithromycin: postmarketing, common
- clevidipine
- clindamycin: 1%
- clodronate
- clofarabine: common
- clomiphene citrate: postmarketing
- clomipramine: 2%
- clonazepam
- clonidine
- clopidogrel
- clozapine: postmarketing, 1%
- codeine
- colestipol
- colestyramine
- conjugated estrogens
- copolymer 1
- cosyntropin
- crizotinib: 1.2% - 2.3%
- cyanocobalamin
- cyclobenzaprine: postmarketing
- cyclophosphamide: postmarketing
- cyproterone
- cyproterone acetate: rare
- cytarabine: 9.73% - 21.4%
- dabigatran etexilate
- dalteparin: 1.16% - 1.72%
- darifenacin
- darunavir
- dasatinib: 2% - 24%
- deferoxamine: very rare
- degarelix
- delamanid
- delavirdine
- deprenyl: infrequent, 3%
- desflurane
- desloratadine: postmarketing
- desmopressin
- dexmedetomidine: postmarketing, uncommon
- dexpanthenol
- dexrazoxane
- diatrizoate
- diazepam
- diclofenac: postmarketing, rare, 0% - 2%
- dicyclomine: postmarketing
- diethylpropion
- diflunisal: postmarketing
- dihydrocodeine: uncommon
- dihydroergotamine: postmarketing, infrequent
- diltiazem: 0.6% - 6.12%
- dipyridamole: 2.6%
- disopyramide
- dobutamine
- docetaxel: postmarketing, uncommon, 0.3% - 9%
- dofetilide: 6%
- dolasetron
- donepezil: infrequent, frequent
- dopamine
- dorzolamide: postmarketing
- doxapram
- doxazosin: 1% - 3.9%
- doxepin: rare
- doxercalciferol: 11.5%
- doxorubicin: common, 1% - 23.4%
- doxycycline
- efavirenz: postmarketing
- eletriptan: infrequent
- eltrombopag: 14%
- emtricitabine
- entacapone: 3%
- ephedrine
- eplerenone
- eprosartan
- ergonovine
- eribulin: 4% - 16%
- erlotinib: 4% - 45%
- ertapenem: 1% - 2.6%
- eslicarbazepine acetate
- esmolol: 1%
- esomeprazole magnesium
- estazolam: infrequent
- estradiol: postmarketing
- estramustine: 3% - 11%
- estramustine phosphate
- etodolac: postmarketing
- etoposide
- etoposide phosphate
- etoricoxib
- everolimus: common, very common, 0.5% - 20%
- exemestane: 0.3% - 15%
- ezetimibe
- febuxostat
- felbamate
- felodipine
- fenofibrate
- fenoldopam
- fenoprofen
- fentanyl: postmarketing, common, 0% - 22%
- ferumoxytol: postmarketing, 1% - 1.1%
- fexofenadine: postmarketing
- fidaxomicin: postmarketing
- finasteride: 0.7% - 2.1%
- flecainide: 4% - 10.3%
- fludarabine: 1% - 22%
- flumazenil
- flunisolide
- fluorescein: very rare
- fluoxetine
- fluphenazine
- flurazepam
- flurbiprofen
- fluticasone: postmarketing
- fluticasone furoate
- fluticasone propionate: very rare, postmarketing, rare
- fluticasone/salmeterol: uncommon
- fluvastatin: postmarketing
- fluvoxamine: infrequent, 2%
- folate
- fondaparinux: rare, uncommon
- formoterol: 2.1% - 4%
- fosaprepitant
- fosaprepitant dimeglumine: postmarketing
- foscarnet
- fosinopril: uncommon
- fosinoprilat
- fosphenytoin: infrequent
- frovatriptan: infrequent
- gabapentin: infrequent
- gadobenate dimeglumine: postmarketing
- gadobutrol: 0.3%
- gadodiamide
- gadofosveset
- gadolinium: 0.2%
- gadopentetate
- gadoteridol: 0.08%
- gadoversetamide
- ganciclovir
- gatifloxacin
- gefitinib: 0% - 3%
- gemcitabine: very common, 0% - 28%
- gemeprost
- gemifloxacin
- glibenclamide
- gliclazide
- glimepiride
- glipizide
- glycerol
- granisetron
- guanfacine: postmarketing
- haloperidol: very rare, postmarketing
- hetastarch: postmarketing
- histamine
- hydralazine: uncommon
- hydrochlorothiazide
- hydrocodone
- hydromorphone: postmarketing, 3.07%
- hydroxocobalamin
- hydroxybutyrate
- hydroxyurea
- ibuprofen
- icodextrin
- ifosfamide: postmarketing
- iloperidone: 2%
- iloprost
- imatinib: common, 0.5% - 21%
- imiquimod: postmarketing
- indacaterol
- indapamide
- indinavir: 0% - 0.3%
- indomethacin
- iodipamide
- iodixanol
- iohexol
- iopamidol
- iopromide
- iotrolan
- ioversol
- ioxaglate
- ioxilan
- ipratropium bromide: 1.8% - 13.2%
- irbesartan: uncommon
- irbesartan-hydrochlorothiazide
- irinotecan: postmarketing, 0% - 22%
- iron sucrose
- isomannide
- isoproterenol
- isosorbide-5-mononitrate
- isradipine: 1.8% - 2.2%
- itraconazole: postmarketing, 0% - 5%
- ivabradine
- ivermectin
- ixabepilone: 1% - 9%
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- labetalol: 1% - 3.8%
- lamivudine
- lamotrigine: infrequent, 0% - 2%
- lanreotide
- lansoprazole
- lapatinib: very common, 0% - 8%
- latanoprost
- leflunomide
- lenalidomide: postmarketing, common, 4.7% - 23.5%
- lercanidipine: common
- letrozole: uncommon, 0.819% - 18%
- leucovorin: postmarketing
- leuprorelin acetate: 3% - 5.4%
- levobunolol
- levocabastine
- levodopa/carbidopa: 1.6%
- levonorgestrel
- lidocaine
- linezolid: 0% - 3.3%
- liraglutide: postmarketing
- lisdexamfetamine dimesylate: 2%
- lisuride
- lomefloxacin
- losartan
- lovastatin: postmarketing
- loxapine: uncommon
- lubiprostone: 2% - 3%
- lurasidone
- mannitol: 1.43% - 5%
- medroxyprogesterone: postmarketing
- medroxyprogesterone acetate: postmarketing, 0.2 - 1.0%
- mefenamic acid
- mefloquine: postmarketing
- megestrol
- megestrol acetate
- meloxicam: 0% - 1.3%
- melphalan
- memantine: 2%
- meropenem
- mesna: 9.2% - 11%
- metformin
- methohexital
- methotrexate
- methylene blue
- methylergometrine
- methylphenidate: 1.2%
- methysergide
- metipranolol
- metoclopramide: postmarketing
- metoprolol: postmarketing, common
- mexiletine: 2.9% - 10.2%
- midazolam
- midodrine
- mifepristone: 16%
- milnacipran: 2%
- minocycline
- mirtazapine: 1% - 1.1%
- misoprostol: postmarketing
- mitomycin C
- mitoxantrone: 0% - 20%
- moclobemide
- modafinil: 1%
- moexiprilat
- molindone
- mometasone: postmarketing
- mometasone furoate
- morphine: 3%
- moxifloxacin
- mycophenolate mofetil: 15.5% - 36.7%
- mycophenolic acid: postmarketing, 30.3% - 36.7%
- nabilone
- nabumetone: 1%
- nadolol
- nalbuphine
- naloxone
- naltrexone: postmarketing
- naproxen: postmarketing
- naratriptan
- natamycin
- nebivolol: 0% - 1%
- nedocromil sodium
- nefazodone: frequent
- nelarabine: 0% - 20%
- nelfinavir
- neostigmine
- nesiritide
- niacin: postmarketing
- nicardipine: 0.7%
- nicorandil: common
- nicotine: 5%
- nifedipine: postmarketing, 1.7% - 6%
- nilotinib: common
- nilutamide: 6.2%
- nimodipine: 1.22%
- nisoldipine
- nitrazepam
- nitric oxide: postmarketing
- nitrofurantoin
- nitroglycerin
- norepinephrine
- norfloxacin: postmarketing
- oCRH
- ofatumumab: 2% - 19%
- ofloxacin: postmarketing
- olanzapine: frequent
- olopatadine
- olsalazine: postmarketing
- omeprazole: very rare
- ondansetron: postmarketing
- oxaliplatin: common, 1% - 13%
- oxaprozin
- oxcarbazepine: very rare
- oxycodone
- oxymorphone
- oxytocin injection: rare
- paclitaxel: postmarketing, rare, common, 1% - 12%
- paliperidone
- palonosetron
- pamidronate: very rare, postmarketing, uncommon, 0% - 35.1%
- pantoprazole: very rare
- parecoxib
- paricalcitol
- paroxetine: infrequent, uncommon
- pazopanib: 1% - 20%
- pemetrexed: 1% - 66%
- penbutolol: 2.1% - 3.4%
- penicillin
- pentamidine: 48.3%
- pentazocine
- pentosan polysulfate
- pentostatin: 8% - 13%
- pentoxifylline
- pergolide: frequent, 4.8%
- perindopril
- perindopril erbumine
- perphenazine
- phencyclidine
- phenylephrine
- phenylpropanolamine
- phenytoin: infrequent
- phosphate
- pilocarpine
- pimecrolimus: 0% - 1.84%
- pindolol: 4% - 6%
- pioglitazone
- pirfenidone
- piroxicam
- pixantrone
- polyoxyethylene
- pomalidomide: 4.67% - 44.6%
- ponatinib: 0% - 21%
- posaconazole: 1.44% - 11.7%
- potassium phosphate
- pralatrexate
- pramipexole: postmarketing, uncommon, 1.2% - 4%
- prasugrel: 4.5% - 4.9%
- pravastatin: postmarketing, 1.6%
- prazosin: 2%
- pregabalin: frequent, 0% - 3%
- prochlorperazine
- progesterone: postmarketing
- propafenone: postmarketing, 0% - 12.7%
- propericiazine
- propofol
- propoxyphene
- propranolol
- prostacyclin: 2%
- quetiapine: postmarketing, frequent, 0% - 3%
- quinapril
- quinaprilat
- quinidine
- rabeprazole: postmarketing
- ramipril: 1.1%
- ramiprilat
- ranitidine
- ranolazine
- rapamycin: 14% - 30%
- rasagiline: 3% - 5%
- rasburicase
- reboxetine
- regadenoson: postmarketing, very common, 10.7% - 29%
- remifentanil: 0% - 1.32%
- reserpine
- retigabine
- retinoic acid: 60%
- ribavirin: common, very common, 5% - 25%
- rifabutin
- rifampicin
- rifapentine
- rifaximin: 6.43%
- riluzole
- rimantadine
- risedronate
- risperidone: frequent, 0% - 5%
- ritonavir
- rivaroxaban
- rivastigmine: infrequent, frequent, 2%
- rizatriptan: frequent
- rofecoxib
- ropinirole: infrequent, 3%
- ropivacaine: 0.2% - 2.6%
- salbutamol: postmarketing, 1.5%
- salmon calcitonin acetate: postmarketing
- saquinavir: common
- sertraline: postmarketing, infrequent
- sevelamer hydrochloride: 10.1% - 16.8%
- sevoflurane: postmarketing
- sibutramine
- sildenafil: 1% - 7%
- simvastatin: postmarketing
- sodium: postmarketing
- sodium acetate
- sodium cromoglycate
- sodium ferric gluconate: 11%
- sodium iothalamate
- sofosbuvir: common, very common
- sorafenib: 1% - 14%
- sotalol: postmarketing, 2% - 21%
- sparfloxacin
- sulfamethoxazole
- sulfasalazine
- sulindac
- sumatriptan: postmarketing, infrequent, common, frequent, 1%
- sunitinib: 2%
- tacrolimus: common, 4% - 29%
- tadalafil: 6%
- tafluprost: postmarketing
- tamoxifen: 7.57% - 7.66%
- tamsulosin: postmarketing, 1.1%
- tapentadol: 1%
- technetium-99m
- teduglutide
- tegaserod
- telavancin: uncommon
- telmisartan: very rare, uncommon, common
- temazepam
- temozolomide: common, 0.446% - 5.36%
- temsirolimus
- teniposide
- tenofovir: postmarketing
- tenofovir disoproxil fumarate: postmarketing
- tenoxicam
- terazosin: 0.5% - 3.1%
- terbutaline: 0% - 2%
- testosterone: postmarketing
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrabenazine
- tetraen
- tetrofosmin: 28%
- thalidomide: postmarketing, 2.94% - 42.2%
- thiothixene
- thyroxine
- tiagabine: frequent
- tiaprofenic acid
- ticagrelor: 7.8% - 13.8%
- tigecycline: 2.7% - 2.9%
- timolol: 1.7%
- tinidazole
- tiopronin
- tipranavir: uncommon, 1%
- tizanidine
- tobramycin: very common, 12.4% - 33.7%
- tofacitinib
- tolcapone: 3%
- topiramate: 1% - 6%
- topotecan: common, 1% - 22%
- toremifene
- trabectedin
- tramadol: postmarketing, rare, uncommon
- trandolapril: postmarketing
- trandolaprilat
- tranexamic acid
- trans 4-cyclohexyl-L-proline
- travoprost: rare, uncommon
- trazodone: 1.1% - 1.3%
- treprostinil
- triamcinolone: postmarketing
- triamcinolone acetonide: postmarketing
- triazolam
- trifluoperazine
- trimethoprim: very rare
- trimethoprim-sulfamethoxazole: very rare
- tropisetron
- trovafloxacin
- v 1784: postmarketing, 1% - 5%
- valdecoxib
- valganciclovir: 3.85% - 11%
- valproate: 1% - 5%
- valsartan
- vandetanib: 0.4%
- vardenafil
- varenicline: uncommon, 1% - 2%
- venlafaxine: uncommon, frequent
- verapamil: postmarketing
- vernakalant: uncommon
- verteporfin
- vinflunine
- vinorelbine: 0% - 7%
- vitamin K
- voriconazole
- warfarin
- zalcitabine
- zaleplon: infrequent
- zanamivir: postmarketing
- ziconotide: common
- zidovudine: postmarketing, uncommon, 5%
- zidovudine/lamivudine
- ziprasidone: uncommon, frequent, 2%
- zoledronic acid: uncommon, common, 1% - 20%
- zolmitriptan: infrequent
- zolpidem: infrequent
- zonisamide: infrequent
- zopiclone: infrequent
- zuclopenthixol
|
Drugs with this indication
|